PRODUCTION OF CHIRAL AMINOALCHOLS
手性氨基醇的生产
基本信息
- 批准号:6070479
- 负责人:
- 金额:$ 14.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-02-01 至 2000-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Chiral vicinal aminoalcohols are important intermediates in the synthesis of many important pharmaceutical compounds. However, their synthesis remains a significant synthetic challenge. Gaining control over the stereochemistry of chiral centers at carbons bearing both the alcohol and amino groups at reasonable cost is the key to the successful production of these important chemical intermediates. Currently, no broadly-applicable route exists for the production of chiral vicinal aminoalcohols in high yield and with high stereochemical purity. The proposed research will develop a general method for the production of chiral vicinal aminoalcohols that relies on a stereoselective alcohol dehydrogenase-catalyzed conversion to introduce two chiral centers in a single step, with high yield and stereoselectivity. In preliminary work with whole cells, it has been shown that multiple enzyme systems present give rise to competing reactions that lower stereochemical purity. The use of an isolated dehydrogenase offers the potential to produce any single diastereomer in high stereochemical purity. The economics of this method depend upon efficient cofactor recycling. In Phase 1 we plan to establish the feasibility of a reaction using a stereoselective alcohol dehydrogenase coupled with formate dehydrogenase for cofactor recycling, laying the foundation for the production a variety of chiral vicinal aminoalcohols. PROPOSED COMMERCIAL APPLICATIONS: Production of key intermediates for existing and new pharmaceutical products
手性邻氨基醇是合成许多重要药物的重要中间体。然而,它们的合成仍然是一个重大的合成挑战。以合理的成本获得对带有醇和氨基的碳上的手性中心的立体化学的控制是成功生产这些重要化学中间体的关键。目前,不存在以高产率和高立体化学纯度生产手性邻位氨基醇的广泛适用的路线。该研究将开发一种生产手性邻氨基醇的通用方法,该方法依赖于立体选择性醇脱氢酶催化转化,在一步中引入两个手性中心,具有高产率和立体选择性。在对全细胞的初步研究中,已经表明存在的多种酶系统引起竞争反应,从而降低立体化学纯度。使用分离的脱氢酶提供了以高立体化学纯度产生任何单一非对映体的可能性。这种方法的经济性取决于有效的辅因子回收。在第一阶段,我们计划建立使用立体选择性醇脱氢酶与甲酸脱氢酶偶联的反应的可行性,用于辅因子再循环,为生产各种手性邻氨基醇奠定基础。拟议商业应用:生产现有和新药品的关键中间体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES DAVID ROZZELL其他文献
JAMES DAVID ROZZELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES DAVID ROZZELL', 18)}}的其他基金
Optimizing Escherichia Coli for Carbonyl reduction
优化大肠杆菌的羰基还原
- 批准号:
6788947 - 财政年份:2004
- 资助金额:
$ 14.2万 - 项目类别:
Optimizing Escherichia coli for Carbonyl Reductions
优化大肠杆菌的羰基还原
- 批准号:
7185817 - 财政年份:2001
- 资助金额:
$ 14.2万 - 项目类别:
Optimizing Escherichia coli for Carbonyl Reductions
优化大肠杆菌的羰基还原
- 批准号:
7050673 - 财政年份:2001
- 资助金额:
$ 14.2万 - 项目类别:














{{item.name}}会员




